Dr. Robert Zaiden Jr., MD

Dr. Zaiden practices at Baptist MD Anderson Cancer Physicians in Jacksonville, Florida.

Dr. Zaiden's NPI, 1821143710, was assigned on January 24, 2007. Dr. Zaiden graduated from St. Matthew's University in 2003. Dr. Zaiden holds Florida license ME103756.

Dr. Zaiden's primary practice is Baptist MD Anderson Cancer Physicians, at 1301 Palm Ave, Jacksonville, FL 32207 in Duval County. The practice phone is (904) 202-7300.

Dr. Zaiden's primary practice is Baptist MD Anderson Cancer Physicians in Jacksonville, Florida. Dr. Zaiden is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Baptist MD Anderson Cancer Physicians. Dmand AI also links Dr. Zaiden to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zaiden practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Zaiden's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Zaiden is board certified in internal medicine by the American Board of Internal Medicine. Dr. Zaiden is licensed in Florida.

Dmand AI lists breast cancer, chronic anemia, colorectal cancer, fluid and electrolyte imbalances, lung cancer, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Zaiden treats.

CMS data shows 833 Medicare services from Dr. Zaiden across 5 procedure codes in 2024, all of them office visits, for 382 Medicare patients. Medicare paid $93,286 for them. Every service was in an office.

CMS counts 382 Medicare patients who saw Dr. Zaiden in 2024. The largest group is 65 to 74, with 167 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zaiden's median patient age at 73, with 32% women.

In 2024, Dr. Zaiden wrote 1,220 Medicare Part D claims for 224 patients. 63% of them were for generic drugs. CMS names the drug for 1,043 of them, across 23 drugs with 11 or more claims each, at $6,158,550 in total drug cost. In 2023, CMS named 661 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Zaiden for performance year 2024, reported as part of a group. Dr. Zaiden accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zaiden as offering telehealth.

Dmand AI links 20 papers to Dr. Zaiden, published from 2009 to 2014. 2014 was the busiest year, with 3. The most frequent topics are Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols and Hodgkin Disease. Dr. Zaiden has published most often in Clin Adv Hematol Oncol. Dr. Zaiden's most frequent co-authors are Dat Cao Pham, MD, Nancy P. Mendenhall, MD and Fauzia Naeem Rana, MD.

Dmand AI links Dr. Zaiden to 6 clinical trials, 3 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include Breast Neoplasms, Rectal Diseases and Colorectal Neoplasms. National Cancer Institute (NCI) sponsors the most, 3.

CMS Open Payments shows 61 general payments to Dr. Zaiden from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 46% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,388.

Dmand AI lists 4 awards for Dr. Zaiden, most recently Physician of the year in 2017. Dr. Zaiden serves on Continuing Medical Education Baptist MD Anderson Cancer Center.

Dr. Zaiden graduated from St. Matthew's University in 2003. Dr. Zaiden is a member of ACP and ASCO.

Dr. Zaiden is in network with 15 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.